Investment into US and European psychedelics companies have been continuously increasing over the past years as mental health gains in importance. Whereas only 12 venture capital transactions were conducted in 2016, the number of transactions … Read more
In the third quarter of 2021, European life sciences companies raised a total of EUR 2.2bn in venture capital funding. Although the performance is almost the same as in the same quarter last year, the … Read more
With a volume of roughly USD 24bn, US biotech companies have already raised more venture capital in the first three quarters of 2021 than in the whole year 2020 (USD 22.4bn). Compared to the first … Read more
The financing volume of European Biotech seed stage companies has significantly increased in recent years. Since 2017, the funding volume has increased by roughly 200% to EUR 296m in 2021 to date. In June this … Read more
While the investment activity from 2017 to 2019 was relatively stable, ranging from EUR 273m to EUR 283m, a significant increase in global VC financing of microbiome companies in 2020 is observable. The volume increased … Read more
The venture capital funding volume raised by European life sciences companies from U.S. investors has experienced an extraordinary growth so far. As of end of August 2021, the gross volume amounts to EUR 3.1bn, which … Read more
The top 10 diagnostics M&A deals of the last five years (by deal size) range from EUR 0.8bn to EUR 20.3bn, with an average deal size of EUR 4.1bn. The largest deal by far was … Read more
With an IPO volume of EUR 3,652m, the IPO of MDax member Siemens Healthineers AG in March 2018 has been the largest offering of the last five years in Life Sciences. The second largest IPO … Read more
After an astonishing development in Q1 2021 with an increase of 106% compared to Q1 2020, the accumulated biotech venture capital funding volume still exceeds the performance of the previous year. In the 1st half … Read more
The aggregated venture capital funding of Life Sciences companies in Europe has significantly increased during the second quarter of 2021, reaching EUR 7,330 million so far (EUR 3,825 million in the first half of 2020). … Read more
